Jan Cornelissen

Prof. Jan Cornelissen is a Full Professor in Hematology at Erasmus MC, part of Erasmus University Rotterdam. His research focuses on hematological malignancies, particularly acute and chronic leukemias, with a strong emphasis on cell transplantation, molecular diagnostics, and treatment outcomes. He leads studies on the efficacy of therapies like tyrosine kinase inhibitors and explores factors influencing patient survival, such as hospital volume effects in acute myeloid leukemia (AML) treatment.

His work integrates clinical and molecular approaches, including deep molecular response quantification in chronic myeloid leukemia (CML) using advanced PCR techniques. Collaborations with international groups, like the EBMT’s Acute Leukemia Working Party, highlight his role in large-scale clinical trials and translational research.

Prof. Cornelissen has supervised 18 academic works and contributed to over 385 research outputs, emphasizing evidence-based strategies for improving leukemia treatment outcomes and patient care.